nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—ABCB1—adrenal gland cancer	0.68	1	CbGaD
Quetiapine—HTR7—sympathetic nervous system—adrenal gland cancer	0.00849	0.134	CbGeAlD
Quetiapine—HTR7—vein—adrenal gland cancer	0.00795	0.126	CbGeAlD
Quetiapine—HTR2A—sympathetic nervous system—adrenal gland cancer	0.0053	0.0836	CbGeAlD
Quetiapine—HTR2A—vein—adrenal gland cancer	0.00496	0.0783	CbGeAlD
Quetiapine—CYP2C19—urine—adrenal gland cancer	0.00454	0.0718	CbGeAlD
Quetiapine—HTR2A—urine—adrenal gland cancer	0.0029	0.0458	CbGeAlD
Quetiapine—CYP3A4—urine—adrenal gland cancer	0.00269	0.0424	CbGeAlD
Quetiapine—CYP2D6—urine—adrenal gland cancer	0.00264	0.0418	CbGeAlD
Quetiapine—H1F0—adrenal cortex—adrenal gland cancer	0.002	0.0316	CbGeAlD
Quetiapine—H1F0—gonad—adrenal gland cancer	0.00165	0.0261	CbGeAlD
Quetiapine—H1F0—cardiac atrium—adrenal gland cancer	0.00165	0.0261	CbGeAlD
Quetiapine—H1F0—pituitary gland—adrenal gland cancer	0.00161	0.0255	CbGeAlD
Quetiapine—H1F0—adrenal gland—adrenal gland cancer	0.00144	0.0228	CbGeAlD
Quetiapine—ADRA2C—adrenal cortex—adrenal gland cancer	0.00113	0.0179	CbGeAlD
Quetiapine—Flupentixol—ABCB1—adrenal gland cancer	0.00109	0.274	CrCbGaD
Quetiapine—HTR7—gonad—adrenal gland cancer	0.00102	0.0161	CbGeAlD
Quetiapine—DRD2—pituitary gland—adrenal gland cancer	0.000942	0.0149	CbGeAlD
Quetiapine—ADRA2C—cardiac atrium—adrenal gland cancer	0.000937	0.0148	CbGeAlD
Quetiapine—HTR1A—adrenal gland—adrenal gland cancer	0.000931	0.0147	CbGeAlD
Quetiapine—ADRA2C—pituitary gland—adrenal gland cancer	0.000915	0.0145	CbGeAlD
Quetiapine—HTR7—adrenal gland—adrenal gland cancer	0.00089	0.0141	CbGeAlD
Quetiapine—ADRA1A—adrenal gland—adrenal gland cancer	0.000858	0.0136	CbGeAlD
Quetiapine—ADRA2C—adrenal gland—adrenal gland cancer	0.000818	0.0129	CbGeAlD
Quetiapine—ADRA2A—gonad—adrenal gland cancer	0.000749	0.0118	CbGeAlD
Quetiapine—ADRA2A—cardiac atrium—adrenal gland cancer	0.000748	0.0118	CbGeAlD
Quetiapine—ADRA2A—pituitary gland—adrenal gland cancer	0.00073	0.0115	CbGeAlD
Quetiapine—HRH1—adrenal gland—adrenal gland cancer	0.000664	0.0105	CbGeAlD
Quetiapine—ADRA2A—adrenal gland—adrenal gland cancer	0.000653	0.0103	CbGeAlD
Quetiapine—HTR2A—gonad—adrenal gland cancer	0.000637	0.0101	CbGeAlD
Quetiapine—HTR2A—pituitary gland—adrenal gland cancer	0.000621	0.00981	CbGeAlD
Quetiapine—Nefazodone—ABCB1—adrenal gland cancer	0.000611	0.153	CrCbGaD
Quetiapine—Olanzapine—ABCB1—adrenal gland cancer	0.000585	0.147	CrCbGaD
Quetiapine—Trazodone—ABCB1—adrenal gland cancer	0.000565	0.142	CrCbGaD
Quetiapine—HTR2A—adrenal gland—adrenal gland cancer	0.000555	0.00876	CbGeAlD
Quetiapine—ABCB1—adrenal cortex—adrenal gland cancer	0.000504	0.00796	CbGeAlD
Quetiapine—Fluphenazine—ABCB1—adrenal gland cancer	0.000458	0.115	CrCbGaD
Quetiapine—ABCB1—gonad—adrenal gland cancer	0.000417	0.00659	CbGeAlD
Quetiapine—ABCB1—pituitary gland—adrenal gland cancer	0.000407	0.00643	CbGeAlD
Quetiapine—Trifluoperazine—ABCB1—adrenal gland cancer	0.000366	0.0919	CrCbGaD
Quetiapine—ABCB1—adrenal gland—adrenal gland cancer	0.000364	0.00574	CbGeAlD
Quetiapine—Clozapine—ABCB1—adrenal gland cancer	0.000305	0.0766	CrCbGaD
Quetiapine—HTR1E—Signaling Pathways—CTNNB1—adrenal gland cancer	3.46e-05	0.000137	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	3.43e-05	0.000136	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—BAD—adrenal gland cancer	3.43e-05	0.000136	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—GNAS—adrenal gland cancer	3.42e-05	0.000135	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	3.39e-05	0.000134	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	3.38e-05	0.000134	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	3.36e-05	0.000133	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	3.34e-05	0.000132	CbGpPWpGaD
Quetiapine—ADRA2C—Hemostasis—TP53—adrenal gland cancer	3.32e-05	0.000131	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—POMC—adrenal gland cancer	3.31e-05	0.000131	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—POMC—adrenal gland cancer	3.31e-05	0.000131	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.31e-05	0.000131	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.31e-05	0.000131	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	3.29e-05	0.00013	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—POMC—adrenal gland cancer	3.28e-05	0.00013	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	3.28e-05	0.00013	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	3.27e-05	0.000129	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—BRAF—adrenal gland cancer	3.27e-05	0.000129	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	3.27e-05	0.000129	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	3.26e-05	0.000129	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	3.26e-05	0.000129	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—BRAF—adrenal gland cancer	3.24e-05	0.000128	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	3.24e-05	0.000128	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	3.23e-05	0.000128	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3.22e-05	0.000127	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	3.22e-05	0.000127	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—POMC—adrenal gland cancer	3.22e-05	0.000127	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	3.2e-05	0.000126	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—BRAF—adrenal gland cancer	3.18e-05	0.000126	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	3.17e-05	0.000125	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—EGFR—adrenal gland cancer	3.17e-05	0.000125	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—POMC—adrenal gland cancer	3.17e-05	0.000125	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	3.16e-05	0.000125	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	3.16e-05	0.000125	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	3.16e-05	0.000125	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	3.15e-05	0.000125	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	3.14e-05	0.000124	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—EGFR—adrenal gland cancer	3.14e-05	0.000124	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	3.14e-05	0.000124	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	3.14e-05	0.000124	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—GNAS—adrenal gland cancer	3.13e-05	0.000124	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	3.13e-05	0.000124	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—BRAF—adrenal gland cancer	3.13e-05	0.000124	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	3.12e-05	0.000124	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	3.12e-05	0.000123	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	3.12e-05	0.000123	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	3.11e-05	0.000123	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	3.11e-05	0.000123	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—BAD—adrenal gland cancer	3.09e-05	0.000122	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	3.09e-05	0.000122	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	3.08e-05	0.000122	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—EGFR—adrenal gland cancer	3.08e-05	0.000122	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	3.08e-05	0.000122	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	3.08e-05	0.000122	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	3.07e-05	0.000121	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—CTNNB1—adrenal gland cancer	3.06e-05	0.000121	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	3.06e-05	0.000121	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	3.06e-05	0.000121	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	3.05e-05	0.000121	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—BAD—adrenal gland cancer	3.05e-05	0.000121	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	3.05e-05	0.000121	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	3.04e-05	0.00012	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	3.04e-05	0.00012	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—EGFR—adrenal gland cancer	3.03e-05	0.00012	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	3.01e-05	0.000119	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	3e-05	0.000119	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	2.99e-05	0.000118	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	2.99e-05	0.000118	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.99e-05	0.000118	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	2.99e-05	0.000118	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	2.96e-05	0.000117	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	2.95e-05	0.000117	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.92e-05	0.000116	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—POMC—adrenal gland cancer	2.92e-05	0.000115	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.92e-05	0.000115	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	2.91e-05	0.000115	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	2.89e-05	0.000114	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	2.86e-05	0.000113	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	2.86e-05	0.000113	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—POMC—adrenal gland cancer	2.85e-05	0.000113	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—POMC—adrenal gland cancer	2.84e-05	0.000112	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	2.81e-05	0.000111	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—POMC—adrenal gland cancer	2.81e-05	0.000111	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	2.81e-05	0.000111	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	2.79e-05	0.00011	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—BRAF—adrenal gland cancer	2.78e-05	0.00011	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	2.78e-05	0.00011	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	2.75e-05	0.000109	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.75e-05	0.000109	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—EGFR—adrenal gland cancer	2.74e-05	0.000108	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	2.73e-05	0.000108	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—TP53—adrenal gland cancer	2.7e-05	0.000107	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—EGFR—adrenal gland cancer	2.69e-05	0.000106	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	2.69e-05	0.000106	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	2.68e-05	0.000106	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	2.66e-05	0.000105	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	2.64e-05	0.000105	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	2.64e-05	0.000104	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	2.63e-05	0.000104	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	2.63e-05	0.000104	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	2.62e-05	0.000104	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	2.59e-05	0.000103	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	2.58e-05	0.000102	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	2.57e-05	0.000102	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	2.54e-05	0.0001	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	2.53e-05	0.0001	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—POMC—adrenal gland cancer	2.51e-05	9.93e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	2.51e-05	9.91e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.46e-05	9.75e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	2.45e-05	9.69e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	2.44e-05	9.64e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	2.43e-05	9.61e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—EGFR—adrenal gland cancer	2.42e-05	9.59e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	2.42e-05	9.59e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	2.42e-05	9.57e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	2.41e-05	9.52e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	2.4e-05	9.5e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.38e-05	9.41e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	2.37e-05	9.38e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.37e-05	9.36e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CTNNB1—adrenal gland cancer	2.36e-05	9.34e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	2.36e-05	9.33e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.35e-05	9.28e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CTNNB1—adrenal gland cancer	2.34e-05	9.27e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	2.34e-05	9.26e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.33e-05	9.23e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	2.33e-05	9.23e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	2.33e-05	9.23e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	2.33e-05	9.21e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	2.3e-05	9.11e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—POMC—adrenal gland cancer	2.3e-05	9.11e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—TP53—adrenal gland cancer	2.3e-05	9.1e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	2.3e-05	9.08e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CTNNB1—adrenal gland cancer	2.3e-05	9.08e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	2.29e-05	9.06e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	2.28e-05	9.03e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	2.28e-05	9.01e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	2.27e-05	8.98e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	2.26e-05	8.95e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CTNNB1—adrenal gland cancer	2.26e-05	8.94e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	2.25e-05	8.92e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	2.25e-05	8.89e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	2.23e-05	8.83e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.23e-05	8.82e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	2.23e-05	8.82e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.19e-05	8.65e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2.15e-05	8.51e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	2.13e-05	8.44e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	2.12e-05	8.4e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	2.12e-05	8.37e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	2.11e-05	8.36e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—POMC—adrenal gland cancer	2.11e-05	8.35e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	2.11e-05	8.33e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	2.1e-05	8.3e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	2.09e-05	8.27e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	2.09e-05	8.26e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	2.09e-05	8.25e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	2.08e-05	8.22e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	2.08e-05	8.22e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	2.07e-05	8.2e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	2.07e-05	8.2e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	2.06e-05	8.15e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	2.05e-05	8.12e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	2.05e-05	8.1e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TP53—adrenal gland cancer	2.04e-05	8.05e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	2.03e-05	8.04e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	2.03e-05	8.01e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	2.02e-05	8e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	2.02e-05	7.97e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	2.01e-05	7.95e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	2.01e-05	7.94e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CTNNB1—adrenal gland cancer	2.01e-05	7.94e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTGS2—adrenal gland cancer	2e-05	7.92e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	1.99e-05	7.87e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	1.98e-05	7.85e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	1.93e-05	7.62e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	1.9e-05	7.52e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—EGFR—adrenal gland cancer	1.87e-05	7.4e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	1.87e-05	7.4e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—EGFR—adrenal gland cancer	1.86e-05	7.35e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.84e-05	7.29e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	1.84e-05	7.27e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—EGFR—adrenal gland cancer	1.82e-05	7.19e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.81e-05	7.17e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.8e-05	7.11e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—EGFR—adrenal gland cancer	1.79e-05	7.08e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	1.77e-05	6.98e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.75e-05	6.92e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	1.74e-05	6.88e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	1.69e-05	6.69e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	1.69e-05	6.69e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	1.68e-05	6.66e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	1.67e-05	6.59e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.63e-05	6.45e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	1.61e-05	6.37e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.59e-05	6.3e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EGFR—adrenal gland cancer	1.59e-05	6.29e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	1.59e-05	6.29e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TP53—adrenal gland cancer	1.57e-05	6.22e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TP53—adrenal gland cancer	1.57e-05	6.21e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TP53—adrenal gland cancer	1.56e-05	6.17e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.54e-05	6.07e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TP53—adrenal gland cancer	1.53e-05	6.04e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.51e-05	5.98e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.51e-05	5.96e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.5e-05	5.94e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TP53—adrenal gland cancer	1.5e-05	5.94e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.5e-05	5.94e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	1.5e-05	5.92e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.48e-05	5.87e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	1.48e-05	5.86e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.48e-05	5.85e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.46e-05	5.76e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	1.44e-05	5.68e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.43e-05	5.66e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	1.42e-05	5.62e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	1.39e-05	5.48e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	1.38e-05	5.45e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.37e-05	5.44e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TP53—adrenal gland cancer	1.35e-05	5.35e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	1.34e-05	5.3e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TP53—adrenal gland cancer	1.33e-05	5.28e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	1.33e-05	5.28e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	1.32e-05	5.22e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.3e-05	5.15e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.27e-05	5.02e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.22e-05	4.81e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	1.2e-05	4.77e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.2e-05	4.74e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	1.2e-05	4.73e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	1.19e-05	4.72e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.19e-05	4.71e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	1.19e-05	4.69e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	1.18e-05	4.65e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	1.17e-05	4.64e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	1.16e-05	4.6e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	1.16e-05	4.58e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	1.13e-05	4.45e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	1.11e-05	4.38e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	1.09e-05	4.31e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	1.02e-05	4.04e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	1e-05	3.98e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	1e-05	3.97e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	1e-05	3.95e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	9.96e-06	3.94e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	9.87e-06	3.9e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	9.84e-06	3.89e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—POMC—adrenal gland cancer	9.81e-06	3.88e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	9.14e-06	3.62e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	7.83e-06	3.1e-05	CbGpPWpGaD
